Insilico Medicine Initiates World’s First Phase III Trial of AI-Driven Drug for IPF #China #Insilico_Medicine #Peking #AI_Drug_Development #Rentosertib

SUGENA's Report on Collaborating with Chinese AI Drug Companies Amid Data Regulations #Japan #Tokyo #AI_Drug_Development #SUGENA #China_Biotech